SCHOTT Pharma AG & Co. KGaA (1SXP) — Tangible Net Worth Ratio
SCHOTT Pharma AG & Co. KGaA (1SXP) has a Tangible Net Worth Ratio of 99.9% as of September 2024. This metric is calculated by deducting intangible assets (€1.12 Million) from net assets (€792.27 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See SCHOTT Pharma AG & Co. KGaA (1SXP) net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
SCHOTT Pharma AG & Co. KGaA Tangible Net Worth Ratio (2020–2024)
This chart shows how SCHOTT Pharma AG & Co. KGaA's Tangible Net Worth Ratio has changed across 5 annual periods from 2020 to 2024. As of September 2024, the ratio stands at 99.9%, reflecting net assets of €792.27 Million with intangible assets of €1.12 Million EUR. Also explore SCHOTT Pharma AG & Co. KGaA annual equity growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for SCHOTT Pharma AG & Co. KGaA (2020–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for SCHOTT Pharma AG & Co. KGaA from 2020 to 2024, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is SCHOTT Pharma AG & Co. KGaA worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 99.9% | €792.27 Million | €1.12 Million | €1.44 Billion | ▲ +0.1 pp |
| 2023 | 99.8% | €692.18 Million | €1.45 Million | €1.23 Billion | ▲ +0.1 pp |
| 2022 | 99.7% | €709.04 Million | €1.92 Million | €1.20 Billion | ▲ +0.1 pp |
| 2021 | 99.6% | €419.42 Million | €1.72 Million | €739.89 Million | ▲ +0.4 pp |
| 2020 | 99.2% | €315.66 Million | €2.61 Million | €596.02 Million | — |